SG3 Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-50,000
Closed -$8.41M 428
2019
Q3
$8.41M Hold
50,000
0.76% 23
2019
Q2
$8.37M Hold
50,000
0.92% 20
2019
Q1
$7.32M Buy
+50,000
New +$7.25M 0.72% 36
2018
Q4
Sell
-30,000
Closed -$5.71M 275
2018
Q3
$5.71M Sell
30,000
-100,000
-77% -$18.4M 0.88% 30
2018
Q2
$21.7M Buy
+130,000
New +$20.9M 4.95% 2
2017
Q1
Sell
-1,400
Closed -$294K 351
2016
Q4
$294K Buy
+1,400
New +$290K 0.05% 173

Other funds holding AGN

SG3 Management's AGN Position: Q1 2020 in Review

SG3 Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,000 shares — an estimated $191K sold.

SG3 Management first reported a position in AGN in Q4 2016 and held it in 9 quarters. The position peaked at $1.26M in Q4 2016. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • SG3 Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • SG3 Management sold 1,000 Allergan plc shares in Q1 2020, an estimated $191K.
  • SG3 Management first reported a position in Allergan plc in Q4 2016 and held it in 9 quarters.
  • SG3 Management's Allergan plc position peaked at $1.26M in Q4 2016.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on SG3 Management's 13F filing for Q1 2020, filed 12 May 2020.